Impaired nitric oxide production, brachial artery reactivity and fish oil in offspring of ischaemic heart disease patients

British Journal of Biomedical Science

Volumn 60, Issue 3, 2003, Pages 144-148

  Yosefy, Chaim ^a   Khalamizer, V ^a   Viskoper, J R ^a   Iaina, A ^b   Manevich, I ^a   London, D ^a   Jafari, J ^a   Magen, E ^a   Wollman, Y ^b   Reisin, L ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Ichilov Medical Center   (Israel)

Author keywords

Endothelium; Fish oils; Nitric oxide; Offspring; Vascular

Indexed keywords

FIBRINOGEN; FISH OIL; LIPID; NITRIC OXIDE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG MEGADOSE; ENDOTHELIUM; FAMILY HISTORY; FEMALE; HEALTH STATUS; HEART FUNCTION; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MEDICAL DOCUMENTATION; NORMAL HUMAN; PRIORITY JOURNAL; PROGENY; URINALYSIS; VASODILATATION;

EID: 10744223697     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2003.11783691     Document Type: Article

References (35)

1. Caridllo C, Kilcoyne CM, Quyyumi AA et al. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998; 97: 851-6.
2. Stroes E, de Bruin T, de Valk H et al. NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc Res 1997; 36: 445-52.
3. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998; 32: S54-S61.
4. Celermajer DS, Adams MR, Clarkson P et al. Passive smoking and impaired endothelium dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
5. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88[5 pt 1]: 2149-55.
6. Park JB, Charbonneau F, Schiffrin EL. Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 2001; 19: 415-20.
7. Massaeli H, Pierce GN. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc Res 1995; 29: 597-603.
8. Lee WH, Hwang TH, Oh GT et al. Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vasc Med 2001; 6: 103-8.
9. Koenig W. Fibrinogen and coronary risk. Curr Cardiol Rep 1999; 1: 112-8.
10. Ernst E. The role fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1-12.
11. Mirshahi F, Vasse M, Vincent L et al. Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cells. Ann N Y Acad Sci 2001; 936: 621-4.
12. Cooke JP, Tsao PS. Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb 1994; 14: 653-5.
13. Shrapnel WS, Calvert GD, Nestel PJ et al. Diet and coronary heart disease. The National Heart Foundation of Australia. Med J Aust 1992; 156: S9-S16.
14. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent response in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-30.
15. Chin JP, Gust AP, Nestel PJ et al. Marine oils dose dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21: 22-8.
16. De Caterina R, Cybulsky MI, Clinton SK et al. The omega-3 fatty acid docoshexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-36.
17. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000; 71(1 suppl): 213S-23S.
18. De Caterina R, Bernini W, Carluccio MA et al. Structural requirements for inhibition of cytokine-induced endothelial activation by unstaturated fatty acids. J Lipid Res 1998; 39: 1062-70.
19. McVeigh GE, Brennan GM, Cohn JN et al. Fish oil improves arterial compliance in non-insulin dependent diabetes mellitus. Arterioscler Thromb 1994; 14: 1425-9.
20. Yosefy C, Viskoper JR, Laszt A et al. The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 83-7.
21. Yosefy C, Viskoper JR, Varon D et al. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis. J Hum Hypertens 1996; 10(Suppl 3): S135-S139.
22. Blonk CM, Bilo HJ, Nauta JJ et al. Dose-response effects of fish oil supplementation in healthy volunteers. Am J Clin Nutr 1990; 52: 120-7.
23. Marangoni F, Angeli MT, Colli S et al. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22;6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta 1993; 1210: 55-62.
24. Reis GJ, Silverman DI, Boucher TM et al. Effects of two types of fish oil supplements on serum lipids and plasma phospholipids fatty acids coronary artery disease. Am J Cardiol 1990; 66: 1171-5.
25. Leander K, Hallqvist J, Reuterwall C et al. Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEEP). Epidemiology 2001; 12: 215-21.
26. Friedewald WT, Levi RI, Fredrickson DS. Estimation of the concentration low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Blum M, Yachnin T, Wollman Y et al. Low nitric oxide production in patients with chronic renal failure. Nephron 1998; 79: 265-8.
28. Suwaidi JA, Hamasaki S, Higano ST et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
29. Anderson TJ, Uehata A, Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.
30. McAllister AS, Atkinson AB, Johnston GD et al. Basal nitric oxide production is impaired in offspring of patients with essential hypertension. Clin Sci (Lond) 1999; 97: 141-7.
31. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
32. Lee BC, Shore AC, Humphreys JM et al. Skin microvascular vasodilatory capacity in offspring of two parents with type 2 diabetes. Diabet Med 2001; 18: 541-5.
33. Gaeta G, De Michele M, Cuomo S et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000; 343: 840-6.
34. Drevon CA. Marine oils and their effects. Nutr Rev 1992; 50: 38-45.
35. Nestel PJ. Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 2000; 71(1 Suppl): 228S-31S.